Meditrina Pharmaceuticals gets OK for drug study
Meditrina Pharmaceuticals gets OK for drug study
Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial
Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial
Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial
Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial
Proellex Reduces Pain for Women With Endometriosis
Repros announces positive results from US phase 2 endometriosis trial
Repros to Host Analyst Meeting, July 24, 2008
Repros to Host Analyst Meeting, July 24, 2008
Repros to Host Analyst Meeting, July 24, 2008
Repros to Host Analyst Meeting, July 24, 2008
Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial i
Endometriosis drug significantly reduces pain in trial
Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial i
Endometriosis Drug Significantly Reduces Pain in Trial
Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial i
Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial i
'Better Treatment' Seen Needed for Endometriosis
Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal as Compared to Topical Testim
